A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
PHASE1
At present, the treatment methods for recurrent cancers are very limited. T...
Status
Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China
A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
PHASE1
For the recurrent and metastatic tumors after first-line treatment (such as...